Showing results (2621-2630 of 9,906) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|May 7, 2003
High-hyperdiploidy in Philadelphia positive adult acute lymphoblastic leukaemia: case-series and review of literatureS Tauro, D McMullan, M Griffiths, et al.
Bone Marrow Transplantation|May 7, 2003
Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphomaG Hess, T Flohr, C Huber, et al.
Bone Marrow Transplantation|May 7, 2003
Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantationS R Solomon, R Nakamura, E J Read, et al.
Bone Marrow Transplantation|May 7, 2003
Loss of hepatitis A virus (HAV) antibodies after peripheral stem cell transplantation (PSCT)M C Dignani, M H Miceli, C M Rosa, et al.
Bone Marrow Transplantation|May 7, 2003
Autoimmune hepatitis following allogeneic PBSCT from an HLA-matched siblingT Ogose, T Watanabe, H Suzuya, et al.
Bone Marrow Transplantation|May 7, 2003
Imminent allograft rejection prevented by donor lymphocyte transfusions: report of two pediatric casesU M Saarinen-Pihkala, M Taskinen, K Vettenranta, et al.
Bone Marrow Transplantation|April 15, 2003
Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimenD Soligo, A Ibatici, E Berti, et al.
Bone Marrow Transplantation|April 15, 2003
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusionsA M Raiola, M T Van Lint, M Valbonesi, et al.
Bone Marrow Transplantation|April 15, 2003
Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published dataA Tartarone, G Romano, R Galasso, et al.
Bone Marrow Transplantation|April 15, 2003
Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissionsA Y L Ho, S Devereux, G J Mufti, et al.
Pageof 991